Position in DBVT
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,866,697
-$132,768 QoQ
Shares Held
113,823
+18.9% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 78 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DBVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $894,401,954 across 107 Biotechnology names. DBVT ranks #47 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
713,946 | $25,266,548 |
All Filings in DBVT
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,866,697 | 113,823 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,999,465 | 95,714 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $429,254 | 22,392 | Shares | Sole | 2026-02-10 | |
| 2023-06-30 | $42,738 | 22,494 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $61,918 | 36,638 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $83,380 | 54,497 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $67,309 | 38,028 | Shares | Sole | 2022-11-10 | |
| 2021-12-31 | $42,660 | 26,663 | Shares | Sole | 2022-02-04 | |
| 2020-09-30 | $35,662 | 20,614 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $85,319 | 19,435 | Shares | Sole | 2020-07-08 | |
| No filing history on record for this holder in this stock. | ||||||